Viatris (VTRS)
Markets established brands, complex generics, and newer innovative medicines worldwide.
$16.99
After hours−0.19 (−1.13%)
At close$17.18(+0.47%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
$0.66
Revenue estimate
$3.80B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.54$0.50$0.62$0.67$0.57$0.59$0.69Pending
Estimate$0.61$0.49$0.56$0.62$0.53$0.50$0.60$0.66
Surprise−11.5%+1.6%+11.5%+7.9%+7.1%+17.5%+14.8%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$3.53B$3.25B$3.58B$3.76B$3.70B$3.52B$3.76BPending
Estimate$3.60B$3.24B$3.47B$3.62B$3.53B$3.36B$3.68B$3.80B
Surprise−2.0%+0.6%+3.3%+3.8%+4.8%+4.8%+2.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.66 | — | — |
| Sep 2027 | $0.70 | — | — |
| Jun 2027 | $0.71 | — | — |
| Mar 2027 | $0.60 | — | — |
| Dec 2026 | $0.59 | — | — |
| Nov 2026 | $0.66 | — | — |
| Aug 2026 | $0.60 | $0.69 | +14.8% |
| May 2026 | $0.50 | $0.59 | +17.5% |
| Feb 2026 | $0.53 | $0.57 | +7.1% |
| Nov 2025 | $0.62 | $0.67 | +7.9% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.66 | — | — | $3.77B | — | — | — |
| Sep 2027 | $0.70 | — | — | $3.91B | — | — | — |
| Jun 2027 | $0.71 | — | — | $3.82B | — | — | — |
| Mar 2027 | $0.60 | — | — | $3.57B | — | — | — |
| Dec 2026 | $0.59 | — | — | $3.71B | — | — | — |
| Nov 5, 2026 | $0.66 | — | — | $3.80B | — | — | — |
| Aug 6, 2026 | $0.60 | $0.69 | +14.8% | $3.68B | $3.76B | +2.2% | −7.7% |
| May 7, 2026 | $0.50 | $0.59 | +17.5% | $3.36B | $3.52B | +4.8% | +9.0% |
| Feb 26, 2026 | $0.53 | $0.57 | +7.1% | $3.53B | $3.70B | +4.8% | −5.2% |
| Nov 6, 2025 | $0.62 | $0.67 | +7.9% | $3.62B | $3.76B | +3.8% | −6.0% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 8, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 6, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 11, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Jul 29, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 5, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 9, 2018 | |||||||
| Feb 28, 2018 | |||||||
| Nov 6, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 1, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 3, 2016 | |||||||
| Feb 10, 2016 | |||||||
| Oct 30, 2015 | |||||||
| Aug 6, 2015 |